Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 47Squamous Cell Carcinoma of Head and Neck 19Carcinoma, Non-Small-Cell Lung 15Neoplasms 12Head and Neck Neoplasms 9Neoplasm Metastasis 8Lung Neoplasms 8Carcinoma, Squamous Cell 7Pancreatic Neoplasms 6Colonic Neoplasms 6Solid Tumors 5Rectal Neoplasms 4Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Colorectal Cancer Metastatic 3Carcinoma 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Recurrence 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Melanoma 2Locally Recurrent Rectal Cancer 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Pancreatic Ductal 2Advanced Solid Tumor 2

Interventions

Radiation 1Paclitaxel 1Hydroxyurea 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × HPV-Negative Squamous Cell Carcinoma × Cetuximab × Clear all
NCT06005324 2025-06-08

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

University of Chicago

Phase 1 Recruiting
36 enrolled

HPV-Negative Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡